160601-84-3

Usage

Uses

Used in Pharmaceutical Industry:
2-carbaMoylisonicotinic acid is utilized as a potential therapeutic agent for a range of conditions due to its diverse biological activities. Its applications span across different areas within medicine, each leveraging its unique properties for specific treatment goals.
Used in Antituberculosis Applications:
In the fight against tuberculosis, 2-carbaMoylisonicotinic acid is considered as a potential antituberculosis agent, offering a new avenue for the development of treatments against this persistent infectious disease.
Used in Cancer Treatment:
As a chemotherapeutic agent, 2-carbaMoylisonicotinic acid is explored for its potential to treat various types of cancer, contributing to the advancement of oncology with its capacity to target and combat malignant cells.
Used in Neurological Disorders:
2-carbaMoylisonicotinic acid is also being investigated for its role in managing neurological disorders, suggesting that it may have neuroprotective or other beneficial effects on the nervous system.
Used in Antimicrobial and Antiviral Development:
2-carbaMoylisonicotinic acid's demonstrated antimicrobial and antiviral activities make it a promising candidate for the development of new drugs to combat infectious diseases, broadening its utility in the medical field.

Upstream product

• 499-80-9 pyridine-2,4-dicarboxylic acid 
• 24195-10-6 pyridine-2,4-dicarboxylic acid 2-methyl ester 
• 25658-36-0 pyridine-2,4-dicarboxylic acid dimethyl ester 
• 57062-14-3 pyridine-2,4-bis(carbonyl)chloride 
• 94413-64-6 2-Cyano-4-carbomethoxypyridine 

Downstream Products

• 1610758-11-6 isonicotinamidium 3-carboxy-4-hydroxybenzenesulfonate monohydrate 
• 67-56-1 methanol 
• 35305-17-0 nitrous oxide 
• 10024-97-2 dinitrogen monoxide 

Relevant academic research and scientific papers

Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876

Despite the long-known fact that the facilitative glucose transporter GLUT1 is one of the key players safeguarding the increase in glucose consumption of many tumor entities even under conditions of normal oxygen supply (known as the Warburg effect), only

Method for preparing 2-acylamino isonicotinic acid from 2-methyl cyanoisonicotinate

The invention discloses a method for preparing 2-acylamino isonicotinic acid from 2-methyl cyanoisonicotinate, wherein the method comprises the steps: adding dioxane, and carrying out a reaction in asodium hydroxide aqueous solution, so as to obviously enhance the yield of 2-acylamino isonicotinic acid. The whole preparation method is simple and easy to operate and is quite suitable for industrial large-scale production.

DOPAMINE D3 RECEPTOR ANTAGONISTS COMPOUNDS

The disclosure is directed to novel dopamine D3 receptor antagonists, processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, including treating drug dependency and psychosis.

Process for the preparation of 2,4-pyridine dicarboxylic acid

A process for the preparation of carboxamides of nitrogen-containing aromatic heterocyclic compounds from the corresponding N-heterocyclic compounds by reaction thereof with formamide in the presence of peroxodisulfuric acid or a peroxodisulfate.